Latest Biologic Stories
The August issue of Atlantic Information Services’s Specialty Pharmacy News offers coverage of recent developments in the biosimilars specialty pharmacy segment, including the Food and Drug
MUMBAI, August 20, 2014 /PRNewswire/ -- Glenmark Pharmaceuticals S.A.
According to new report from BCC Research,the global market for multiple sclerosis (MS) disease-modifying products reached nearly $10.9 billion in 2013.
-- Two of Company's Anti-Infective Programs to be Presented at Highly Regarded Scientific Conference: Pertussis and C. difficile -- ROCKVILLE, Md., Aug.
Company To Pursue Next Stage of Development REDWOOD CITY, Calif., Aug. 14, 2014 /PRNewswire/ -- Coherus BioSciences, Inc.
CARLSBAD, Calif., Aug. 13, 2014 /PRNewswire/ -- Advanced Biologics announced today the acceptance for publication of a new OsteoAMP study to be published in the Journal of Spine.
-- Keynote Speaker: Mark Pimentel, M.D., FRCP(C), Director, GI Motility Program and Laboratory, Cedars-Sinai Medical Center; Chairman, Synthetic Biologics' C-IBS Clinical Advisory Board --
-- SYN-005 Program Targeting Pertussis Toxin to be Highlighted in Oral Presentation -- ROCKVILLE, Md., Aug.
Twenty-five pharmaceutical companies being asked to adopt common principles re biosimilars on patient safety, lobbying and business partnerships. DETROIT, Aug.
- A ceramic container used inside a fuel-fired kiln to protect pots from the flame.